Blood-Based Non-Invasive Screening Market Size, Share, and Trends 2026 to 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology 

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Blood-Based Non-Invasive Screening Market 

5.1. COVID-19 Landscape: Blood-Based Non-Invasive Screening Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Blood-Based Non-Invasive Screening Market, By Technology

8.1. Blood-Based Non-Invasive Screening Market, by Technology

8.1.1. Nucleic Acid Testing (NAT)

8.1.1.1. Market Revenue and Forecast

8.1.2. Next-Generation Sequencing (NGS)

8.1.2.1. Market Revenue and Forecast  

Chapter 9. Global Blood-Based Non-Invasive Screening Market, By Product

9.1. Blood-Based Non-Invasive Screening Market, by Product

9.1.1. Reagents and Kits

9.1.1.1. Market Revenue and Forecast

9.1.2. Software and AI-Services

9.1.2.1. Market Revenue and Forecast

Chapter 10. Global Blood-Based Non-Invasive Screening Market, By Application

10.1. Blood-Based Non-Invasive Screening Market, by Application

10.1.1. Infectious Disease Screening

10.1.1.1. Market Revenue and Forecast

10.1.2. Oncology (Liquid Biopsy)

10.1.2.1. Market Revenue and Forecast

Chapter 11. Global Blood-Based Non-Invasive Screening Market, By Test Type

11.1. Blood-Based Non-Invasive Screening Market, by Test Type

11.1.1. Automated Screening

11.1.1.1. Market Revenue and Forecast

11.1.2. Point-of-Care (POC)/Home Kits

11.1.2.1. Market Revenue and Forecast

Chapter 12. Global Blood-Based Non-Invasive Screening Market, By End-User

12.1. Blood-Based Non-Invasive Screening Market, by End-User

12.1.1. Hospitals and Blood Banks

12.1.1.1. Market Revenue and Forecast

12.1.2. Specialized Diagnostic Labs

12.1.2.1. Market Revenue and Forecast

Chapter 13. Global Blood-Based Non-Invasive Screening Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Technology

13.1.2. Market Revenue and Forecast, by Product

13.1.3. Market Revenue and Forecast, by Application

13.1.4. Market Revenue and Forecast, by Test Type

13.1.5. Market Revenue and Forecast, by End-User

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Technology

13.1.6.2. Market Revenue and Forecast, by Product

13.1.6.3. Market Revenue and Forecast, by Application

13.1.6.4. Market Revenue and Forecast, by Test Type

13.1.6.5. Market Revenue and Forecast, by End-User  

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Technology

13.1.7.2. Market Revenue and Forecast, by Product

13.1.7.3. Market Revenue and Forecast, by Application

13.1.7.4. Market Revenue and Forecast, by Test Type

13.1.7.5. Market Revenue and Forecast, by End-User

13.2. Europe

13.2.1. Market Revenue and Forecast, by Technology

13.2.2. Market Revenue and Forecast, by Product

13.2.3. Market Revenue and Forecast, by Application

13.2.4. Market Revenue and Forecast, by Test Type  

13.2.5. Market Revenue and Forecast, by End-User  

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Technology

13.2.6.2. Market Revenue and Forecast, by Product

13.2.6.3. Market Revenue and Forecast, by Application

13.2.7. Market Revenue and Forecast, by Test Type  

13.2.8. Market Revenue and Forecast, by End-User  

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Technology

13.2.9.2. Market Revenue and Forecast, by Product

13.2.9.3. Market Revenue and Forecast, by Application

13.2.10. Market Revenue and Forecast, by Test Type

13.2.11. Market Revenue and Forecast, by End-User

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Technology

13.2.12.2. Market Revenue and Forecast, by Product

13.2.12.3. Market Revenue and Forecast, by Application

13.2.12.4. Market Revenue and Forecast, by Test Type

13.2.13. Market Revenue and Forecast, by End-User

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Technology

13.2.14.2. Market Revenue and Forecast, by Product

13.2.14.3. Market Revenue and Forecast, by Application

13.2.14.4. Market Revenue and Forecast, by Test Type

13.2.15. Market Revenue and Forecast, by End-User

13.3. APAC

13.3.1. Market Revenue and Forecast, by Technology

13.3.2. Market Revenue and Forecast, by Product

13.3.3. Market Revenue and Forecast, by Application

13.3.4. Market Revenue and Forecast, by Test Type

13.3.5. Market Revenue and Forecast, by End-User

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Technology

13.3.6.2. Market Revenue and Forecast, by Product

13.3.6.3. Market Revenue and Forecast, by Application

13.3.6.4. Market Revenue and Forecast, by Test Type

13.3.7. Market Revenue and Forecast, by End-User

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Technology

13.3.8.2. Market Revenue and Forecast, by Product

13.3.8.3. Market Revenue and Forecast, by Application

13.3.8.4. Market Revenue and Forecast, by Test Type

13.3.9. Market Revenue and Forecast, by End-User

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Technology

13.3.10.2. Market Revenue and Forecast, by Product

13.3.10.3. Market Revenue and Forecast, by Application

13.3.10.4. Market Revenue and Forecast, by Test Type

13.3.10.5. Market Revenue and Forecast, by End-User

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Technology

13.3.11.2. Market Revenue and Forecast, by Product

13.3.11.3. Market Revenue and Forecast, by Application

13.3.11.4. Market Revenue and Forecast, by Test Type

13.3.11.5. Market Revenue and Forecast, by End-User

13.4. MEA

13.4.1. Market Revenue and Forecast, by Technology

13.4.2. Market Revenue and Forecast, by Product

13.4.3. Market Revenue and Forecast, by Application

13.4.4. Market Revenue and Forecast, by Test Type

13.4.5. Market Revenue and Forecast, by End-User

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Technology

13.4.6.2. Market Revenue and Forecast, by Product

13.4.6.3. Market Revenue and Forecast, by Application

13.4.6.4. Market Revenue and Forecast, by Test Type

13.4.7. Market Revenue and Forecast, by End-User

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Technology

13.4.8.2. Market Revenue and Forecast, by Product

13.4.8.3. Market Revenue and Forecast, by Application

13.4.8.4. Market Revenue and Forecast, by Test Type

13.4.9. Market Revenue and Forecast, by End-User

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Technology

13.4.10.2. Market Revenue and Forecast, by Product

13.4.10.3. Market Revenue and Forecast, by Application

13.4.10.4. Market Revenue and Forecast, by Test Type

13.4.10.5. Market Revenue and Forecast, by End-User

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Technology

13.4.11.2. Market Revenue and Forecast, by Product

13.4.11.3. Market Revenue and Forecast, by Application

13.4.11.4. Market Revenue and Forecast, by Test Type

13.4.11.5. Market Revenue and Forecast, by End-User

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Technology

13.5.2. Market Revenue and Forecast, by Product

13.5.3. Market Revenue and Forecast, by Application

13.5.4. Market Revenue and Forecast, by Test Type

13.5.5. Market Revenue and Forecast, by End-User

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Technology

13.5.6.2. Market Revenue and Forecast, by Product

13.5.6.3. Market Revenue and Forecast, by Application

13.5.6.4. Market Revenue and Forecast, by Test Type

13.5.7. Market Revenue and Forecast, by End-User

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Technology

13.5.8.2. Market Revenue and Forecast, by Product

13.5.8.3. Market Revenue and Forecast, by Application

13.5.8.4. Market Revenue and Forecast, by Test Type

13.5.8.5. Market Revenue and Forecast, by End-User

Chapter 14. Company Profiles

14.1. Abbott Laboratories

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. F. Hoffmann-La Roche Ltd.

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Guardant Health, Inc.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Illumina, Inc.

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Thermo Fisher Scientific Inc.

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Grail

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Siemens Healthineers AG

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Bio-Rad Laboratories, Inc.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Exact Sciences Corporation

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Grifols, S.A.

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms